Cytoplasmic Phospholipase A2 Deletion Enhances Colon Tumorigenesis
- 1 April 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 65 (7) , 2636-2643
- https://doi.org/10.1158/0008-5472.can-04-3446
Abstract
Cellular pools of free arachidonic acid are tightly controlled through enzymatic release of the fatty acid and subsequent utilization by downstream enzymes including the cyclooxygenases. Arachidonic acid cleavage from membrane phospholipids is accomplished by the actions of phospholipase A2 (PLA2). Upon release, free arachidonic acid provides substrate for the synthesis of eicosanoids. However, under certain conditions, arachidonic acid may participate in ceramide-mediated apoptosis. Disruption of arachidonic acid homeostasis can shift the balance of cell turnover in favor of tumorigenesis, via overproduction of tumor-promoting eicosanoids or alternatively by limiting proapoptotic signals. In the following study, we evaluated the influence of genetic deletion of a key intracellular phospholipase, cytoplasmic PLA2 (cPLA2), on azoxymethane-induced colon tumorigenesis. Heterozygous and null mice, upon treatment with the organotropic colon carcinogen, azoxymethane, developed a significant (P < 0.05) increase in colon tumor multiplicity (7.2-fold and 5.5-fold, respectively) relative to their wild-type littermates. This enhanced tumor sensitivity may be explained, in part, by the attenuated levels of apoptosis observed by terminal deoxynucleotidyl transferase–mediated nick end labeling staining within the colonic epithelium of heterozygous and null mice (≈50% of wild type). The lower frequency of apoptotic cells corresponded with reduced ceramide levels (69% and 46% of wild-type littermates, respectively). Remarkably, increased tumorigenesis resulting from cPLA2 deletion occurred despite a significant reduction in prostaglandin E2 production, even in cyclooxygenase-2–overexpressing tumors. These data contribute new information that supports a fundamental role of cPLA2 in the control of arachidonic acid homeostasis and cell turnover. Our findings indicate that the proapoptotic role of cPLA2 in the colon may supercede its contribution to eicosanoid production in tumor development.Keywords
This publication has 57 references indexed in Scilit:
- Potentiation of Tumor Necrosis Factor α-induced Secreted Phospholipase A2 (sPLA2)-IIA Expression in Mesangial Cells by an Autocrine Loop Involving sPLA2 and Peroxisome Proliferator-activated Receptor α ActivationJournal of Biological Chemistry, 2003
- Cross-talk between Cytosolic Phospholipase A2α (cPLA2α) and Secretory Phospholipase A2 (sPLA2) in Hydrogen Peroxide-induced Arachidonic Acid Release in Murine Mesangial CellsJournal of Biological Chemistry, 2003
- Inhibition of tumor angiogenesis by non-steroidal anti-inflammatory drugs: emerging mechanisms and therapeutic perspectivesDrug Resistance Updates, 2001
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Oxalate-induced ceramide accumulation in Madin-Darby canine kidney and LLC-PK1 cellsKidney International, 2000
- Cytokine-mediated cPLA2phosphorylation is regulated by multiple MAPK family membersFEBS Letters, 2000
- Azoxymethane induces KI-ras activation in the tumor resistant AKR/J mouse colonMolecular Carcinogenesis, 2000
- Nonsteroidal Antiinflammatory Drugs Inhibit the Proliferation of Colon Adenocarcinoma Cells: Effects on Cell Cycle and ApoptosisExperimental Cell Research, 1996
- Induction of aberrant crypts in murine colon with varying sensitivity to colon carcinogenesisCancer Letters, 1995
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959